Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of L-NAME and Midodrine to Increase MAP
This study is currently recruiting participants.
Verified May 2013 by Department of Veterans Affairs
Study NCT00835224   Information provided by Department of Veterans Affairs

First Received on January 30, 2009.   Last Updated on May 8, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Orthostatic Hypotension
Spinal Cord Injury
Additional conditions recognized in this trial
Hypotension
Hypotension, Orthostatic
Spinal Cord Injuries
More general conditions related to this trial
Autonomic Nervous System Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Nervous System Diseases
Orthostatic Intolerance
Primary Dysautonomias
Spinal Cord Diseases
Trauma, Nervous System
Vascular Diseases
Wounds and Injuries
Interventions listed in this trial
L-NAME
Midodrine Hydrochloride
Additional drug interventions recognized in this trial
Midodrine
NG-Nitroarginine Methyl Ester
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-1 Receptor Agonists
Adrenergic alpha-Agonists
Autonomic Agents
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Department of Veterans Affairs


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services